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Abstract
© 2018 Wolters Kluwer Health, Inc. All rights reserved. This work presents the results of in-vitro
biological activity studies of three novel anticancer agents, phosphonium salts based on the 3-
hydroxypyridine  scaffold,  including  one  derivative  of  4-deoxypyridoxine.  Proliferation  and
viability of cells treated with these compounds was assessed by the colony formation and 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assays. Effects of the compounds on
apoptosis and cell cycle were studied by flow cytometry using annexin V-FITC/propidium iodide
and propidium iodide staining, respectively. The influence of the compounds on mitochondrial
membrane potential and intracellular reactive oxygen species was evaluated using tetramethyl
rhodamine ethyl and DCFHA staining. Western blot analysis was used to study the changes in
the expression of  Bcl-xL,  Bax,  and caspase-3 apoptotic  proteins.  The treatment of  ovarian
adenocarcinoma cells OVCAR-4 with the tested compounds inhibited the growth and induced
cell  cycle  arrest  in  the  G1  phase.  3-Hydroxypyridine  derivatives  induced  apoptosis  by
hyperexpression  of  Bax  and caspase-3,  whereas  4-deoxypyridoxine  derivative  induced cell
death partly  by reactive oxygen species generation and caspase-3 hyperexpression.  These
results indicate that the quaternary phosphonium salts studied represent potential therapeutic
agents for the treatment of ovarian cancer.
http://dx.doi.org/10.1097/CAD.0000000000000642
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